|
Dalton is a GMP Manufacturer and has
capabilities in GMP synthesis to support
the pharmaceutical and biopharmaceutical industry. Peptides, Oligos and
small molecules are manufactured in our new state-of-the-art cGMP facility.
We are currently involved with small scale cGMP synthesis of active
pharmaceutical ingredients in many drug classes. Some of the projects have
originated as Dalton contract research, and some as custom synthesis. All
are supported by our chemistry expertise, cGMP compliance and extensive
quality control.
Our GMP Manufacturing facility
presently has 1 GMP product in Phase I,
and 2 GMP products in Phase III. We are
manufacturing Virulizin for Lorus Therapeutics to be used in pancreatic
cancer treatment.
Learn more about our GMP Manufacturing Facility. |